Cure Rare Disease (CRD), a nonprofit biotechnology organization developing genetic therapies for ultra-rare diseases, today announced the successful completion of a pre-Investigational New Drug ...

CALGARY, AB / ACCESS Newswire / July 30, 2025 / Primary Hydrogen Corp. (TSXV:HDRO)(FRA:83W0)(OTCQB:HNATF) ("Primary" or the "Company") is pleased to provide an update on the exploration program at the ...